Regenerex Pharma Reports Director Changes & Compensation Updates
Ticker: RGPX · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1357878
| Field | Detail |
|---|---|
| Company | Regenerex Pharma, Inc. (RGPX) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
TL;DR
Regenerex Pharma (RGPX) filed an 8-K detailing director changes and executive pay adjustments. Watch for updates.
AI Summary
Regenerex Pharma, Inc. filed an 8-K on March 31, 2025, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a shift in corporate governance and potential adjustments to how key personnel are compensated.
Why It Matters
Changes in board composition and executive compensation can signal strategic shifts or reflect responses to performance, impacting investor confidence and future company direction.
Risk Assessment
Risk Level: medium — Changes in directors and compensation can introduce uncertainty regarding future strategy and financial performance.
Key Players & Entities
- REGENEREX PHARMA, INC. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- March 31, 2025 (date) — Date of Report
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers' and 'Election of Directors', but the specific names and details of these changes are not provided in the provided text snippet.
What are the details of the compensatory arrangements for certain officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item information, but the specific details of these arrangements are not included in the provided text.
When was this 8-K filing submitted?
The filing was submitted on April 2, 2025, and the date of the report is March 31, 2025.
What is Regenerex Pharma, Inc.'s primary business?
Regenerex Pharma, Inc. is in the 'PHARMACEUTICAL PREPARATIONS' industry, SIC code 2834.
Has Regenerex Pharma, Inc. had previous company names?
Yes, the company was formerly known as PEPTIDE TECHNOLOGIES, INC. and Eternelle Skincare Products Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding REGENEREX PHARMA, INC. (RGPX).